testing in cultured myotubes and mouse skeletal muscle mass, elucidated tomatidine as a little molecule inhibitor of skeletal muscle atrophy. The latter outcome is mediated from the hitherto unfamiliar skill of DYRK1B to activate the PI3K/mTOR/AKT pathway, which is thought to stabilize GLI protei